#METABOLOMICS WORKBENCH MaMa_20230716_065245 DATATRACK_ID:4162 STUDY_ID:ST002791 ANALYSIS_ID:AN004541 PROJECT_ID:PR001739
VERSION             	1
CREATED_ON             	July 24, 2023, 6:22 am
#PROJECT
PR:PROJECT_TITLE                 	Nucleotide metabolism in pancreatic cancer cells
PR:PROJECT_SUMMARY               	The Experiment analyzes the cancer cell metabolism in two pancreatic cancer cell
PR:PROJECT_SUMMARY               	lines, (i.e. Panc02 and KPC FC 1245) after the knockdown of the protein cytidine
PR:PROJECT_SUMMARY               	deaminase (CDA). Murine Panc02 and KPC FC1245 pancreatic cancer cell lines were
PR:PROJECT_SUMMARY               	genetically engineered using a doxycycline inducible CRISPR/Cas9 platform with a
PR:PROJECT_SUMMARY               	target specific gRNA for CDA and a control non-targeting NT gRNA. CDA knockdown
PR:PROJECT_SUMMARY               	cells show a significant decrease of intracellular uridine levels and the
PR:PROJECT_SUMMARY               	accumulation of intracellular cytidine. Consistent with the decrease in
PR:PROJECT_SUMMARY               	intracellular uridine, sgCda cells show reduced intracellular levels of UMP, UDP
PR:PROJECT_SUMMARY               	and UTP compared to sgNT cells while we see no change in adenine and cytosine
PR:PROJECT_SUMMARY               	nucleotides (i.e., AMP, ADP, ATP and CMP, CDP, CTP, respectively) or in
PR:PROJECT_SUMMARY               	UDP-hexose.
PR:INSTITUTE                     	VIB Center for Cancer Biology
PR:LAST_NAME                     	Mazzone
PR:FIRST_NAME                    	Massimiliano
PR:ADDRESS                       	Herestraat 49, box 912, Leuven, Flemish Brabant, 3000, Belgium
PR:EMAIL                         	massimiliano.mazzone@kuleuven.be
PR:PHONE                         	+32-16-37.32.13
#STUDY
ST:STUDY_TITLE                   	Nucleotide metabolism in pancreatic cancer cells
ST:STUDY_SUMMARY                 	The Experiment analyzes the cancer cell metabolism in two pancreatic cancer cell
ST:STUDY_SUMMARY                 	lines, (i.e. Panc02 and KPC FC 1245) after the knockdown of the protein cytidine
ST:STUDY_SUMMARY                 	deaminase (CDA). Murine Panc02 and KPC FC1245 pancreatic cancer cell lines were
ST:STUDY_SUMMARY                 	genetically engineered using a doxycycline inducible CRISPR/Cas9 platform with a
ST:STUDY_SUMMARY                 	target specific gRNA for CDA and a control non-targeting NT gRNA. CDA knockdown
ST:STUDY_SUMMARY                 	cells show a significant decrease of intracellular uridine levels and the
ST:STUDY_SUMMARY                 	accumulation of intracellular cytidine. Consistent with the decrease in
ST:STUDY_SUMMARY                 	intracellular uridine, sgCda cells show reduced intracellular levels of UMP, UDP
ST:STUDY_SUMMARY                 	and UTP compared to sgNT cells while we see no change in adenine and cytosine
ST:STUDY_SUMMARY                 	nucleotides (i.e., AMP, ADP, ATP and CMP, CDP, CTP, respectively) or in
ST:STUDY_SUMMARY                 	UDP-hexose.
ST:INSTITUTE                     	VIB-KU Leuven
ST:LAST_NAME                     	Mazzone
ST:FIRST_NAME                    	Massimiliano
ST:ADDRESS                       	Campus Gasthuisberg Herestraat 49, box 912 B-3000 Leuven Belgium
ST:EMAIL                         	massimiliano.mazzone@kuleuven.vib.be
ST:PHONE                         	+32-16-37.32.13
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:GENDER                        	Not applicable
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	KPC_NT_1	Genotype:sgNT | Cell Line:KPC_FC1245	Protein_BCA=3,852830189; RAW_FILE_NAME=MCF000545_ST91.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_NT_2	Genotype:sgNT | Cell Line:KPC_FC1245	Protein_BCA=3,725471698; RAW_FILE_NAME=MCF000545_ST92.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_NT_3	Genotype:sgNT | Cell Line:KPC_FC1245	Protein_BCA=4,10990566; RAW_FILE_NAME=MCF000545_ST93.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_NT_4	Genotype:sgNT | Cell Line:KPC_FC1245	Protein_BCA=3,421226415; RAW_FILE_NAME=MCF000545_ST94.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_CDAKD_1	Genotype:sgCDA | Cell Line:KPC_FC1245	Protein_BCA=3,980188679; RAW_FILE_NAME=MCF000545_ST99.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_CDAKD_2	Genotype:sgCDA | Cell Line:KPC_FC1245	Protein_BCA=4,175943396; RAW_FILE_NAME=MCF000545_ST100.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_CDAKD_3	Genotype:sgCDA | Cell Line:KPC_FC1245	Protein_BCA=3,664150943; RAW_FILE_NAME=MCF000545_ST101.mzML
SUBJECT_SAMPLE_FACTORS           	-	KPC_CDAKD_4	Genotype:sgCDA | Cell Line:KPC_FC1245	Protein_BCA=3,878773585; RAW_FILE_NAME=MCF000545_ST102.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_CDAKD_1	Genotype:sgCDA | Cell Line:Panc02	Protein_BCA=531,29; RAW_FILE_NAME=MCF000215_SR01.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_CDAKD_2	Genotype:sgCDA | Cell Line:Panc02	Protein_BCA=591,876; RAW_FILE_NAME=MCF000215_SR02.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_CDAKD_3	Genotype:sgCDA | Cell Line:Panc02	Protein_BCA=572,783; RAW_FILE_NAME=MCF000215_SR03.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_CDAKD_4	Genotype:sgCDA | Cell Line:Panc02	Protein_BCA=588,8695; RAW_FILE_NAME=MCF000215_SR04.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_NT_1	Genotype:sgNT | Cell Line:Panc02	Protein_BCA=532,9435; RAW_FILE_NAME=MCF000215_SR13.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_NT_2	Genotype:sgNT | Cell Line:Panc02	Protein_BCA=583,156; RAW_FILE_NAME=MCF000215_SR14.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_NT_3	Genotype:sgNT | Cell Line:Panc02	Protein_BCA=545,422; RAW_FILE_NAME=MCF000215_SR15.mzML
SUBJECT_SAMPLE_FACTORS           	-	Panc02_NT_4	Genotype:sgNT | Cell Line:Panc02	Protein_BCA=579,248; RAW_FILE_NAME=MCF000215_SR16.mzML
#COLLECTION
CO:COLLECTION_SUMMARY            	On day 2, cells were harvested on ice by washing them once in ice-cold saline
CO:COLLECTION_SUMMARY            	solution (9 g/l NaCl). Cells were covered with 250 μl of pre-cooled 80%
CO:COLLECTION_SUMMARY            	methanol for 2 minutes scraped, transferred to fresh vials, and precipitated
CO:COLLECTION_SUMMARY            	overnight at -80°C. Then they were centrifuged at 20.009 g for 15min, 4 degrees
CO:COLLECTION_SUMMARY            	C and supernatant transferred to an M/S vial.
CO:SAMPLE_TYPE                   	Cultured cells
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Cancer cells were cultured in DMEM medium supplemented with 10% FBS and 1%
TR:TREATMENT_SUMMARY             	Pen/Strep in 6-well plates. On day 1, the cells and empty wells (for background
TR:TREATMENT_SUMMARY             	noise control), were washed with PBS, and replenished with DMEM containing 10%
TR:TREATMENT_SUMMARY             	FBS, 1% Pen/Strep, 5.5 mM glucose, 2 mM glutamine, 1% Pen/Strep, 0.1 mM cytidine
TR:TREATMENT_SUMMARY             	(Sigma-Aldrich), or alternately, 0.1 mM labelled cytidine (13C9, 98% 15N3,
TR:TREATMENT_SUMMARY             	96-98%, Eurisotop) for 48h.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The samples were centrifuged at 20.000 x g for 15 min at 4°C, supernatant was
SP:SAMPLEPREP_SUMMARY            	transferred to appropriate M/S vial for analysis. The cell pellet was dissolved
SP:SAMPLEPREP_SUMMARY            	in 100 μl of 200 mM NaOH (for 20 minutes at 95°C), and the protein
SP:SAMPLEPREP_SUMMARY            	concentration was determined by using bicinchoninic acid (BCA) reagent method.
SP:PROCESSING_STORAGE_CONDITIONS 	-80℃
SP:EXTRACT_STORAGE               	-80℃
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	C18 IP REVERSE PHASE
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Waters Acquity
CH:COLUMN_NAME                   	Waters Acquity UPLC HSS T3 (150 x 2.1mm, 1.8um)
CH:SOLVENT_A                     	100% water; 10mM tributylamine; 15mM acetic acid
CH:SOLVENT_B                     	100% methanol
CH:FLOW_GRADIENT                 	The gradient started with 5% solvent B and 95% solvent A and remained at 5% B
CH:FLOW_GRADIENT                 	until 2min post injection. A linear gradient to 37% B was carried out until 7min
CH:FLOW_GRADIENT                 	and increased to 41% until 14min. Between 14 and 26 minutes the gradient
CH:FLOW_GRADIENT                 	increased to 95% of B and remained at 95% B for 4 minutes. At 30 min the
CH:FLOW_GRADIENT                 	gradient returned to 5% B. The chromatography was stopped at 40 min.
CH:FLOW_RATE                     	0.25 mL/min
CH:COLUMN_TEMPERATURE            	40
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	EI-Maven polly, ThermoFisher Xcalibur, Metabolites were annotated using the
MS:MS_COMMENTS                   	inhouse standard metabolite library- elution time and m/z values.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	AUC
MS_METABOLITE_DATA_START
Samples	KPC_NT_1	KPC_NT_2	KPC_NT_3	KPC_NT_4	KPC_CDAKD_1	KPC_CDAKD_2	KPC_CDAKD_3	KPC_CDAKD_4	Panc02_CDAKD_1	Panc02_CDAKD_2	Panc02_CDAKD_3	Panc02_CDAKD_4	Panc02_NT_1	Panc02_NT_2	Panc02_NT_3	Panc02_NT_4
Factors	Genotype:sgNT | Cell Line:KPC_FC1245	Genotype:sgNT | Cell Line:KPC_FC1245	Genotype:sgNT | Cell Line:KPC_FC1245	Genotype:sgNT | Cell Line:KPC_FC1245	Genotype:sgCDA | Cell Line:KPC_FC1245	Genotype:sgCDA | Cell Line:KPC_FC1245	Genotype:sgCDA | Cell Line:KPC_FC1245	Genotype:sgCDA | Cell Line:KPC_FC1245	Genotype:sgCDA | Cell Line:Panc02	Genotype:sgCDA | Cell Line:Panc02	Genotype:sgCDA | Cell Line:Panc02	Genotype:sgCDA | Cell Line:Panc02	Genotype:sgNT | Cell Line:Panc02	Genotype:sgNT | Cell Line:Panc02	Genotype:sgNT | Cell Line:Panc02	Genotype:sgNT | Cell Line:Panc02
Cytidine	28223402	3174356	13974296	31187797	164148316	61203529	63084877	980534	1305310162	8926774274	8648320948	1274710013	3498402947	3955412221	2381821314	2632888878
UDP	108991256	137762094	115042954	132107886	8567421	61932077	66842732	68226758	2193978993	1743644098	1824406797	1850506516	2315864644	2631132415	2437428576	287336616
UMP	17417638	2477793	14165911	21819336	10551369	649234	7305842	5885353	3135728	2601483191	2887550602	306684733	2786814761	2982213233	2948325387	2904765167
Uridine	24998308	21073763	15980564	21611477	137563	5642838	5292695	8223912	1657144298	1808722227	2112223411	2924058647	6068804178	8685912619	5299654001	6124843779
UTP	198402728	254619974	279115095	203107877	15522391	156186558	178140117	185742304	5315675913	4080802251	4203030526	4182507181	5437949985	6478508159	6423958662	7361952705
CDP	1122614	1327743	102451	1173586	2345728	2240025	2058941	1981533	1279400955	1031831161	1081047069	109651369	1067314806	116168165	1086515814	1241615994
CMP	502818	1067148	540898	1189809	1299076	696441	586268	590406	1147917069	1072233125	1133450625	1114038746	1100599525	10944388	1052572234	1114117923
CTP	44755367	57108646	60025299	47160202	44308309	45344671	52586144	57023085	2629652516	196619333	2040199073	2043945541	1975033969	2215110879	2267599573	2599611926
UDP-hexose	172424796	199789986	2655594	144894659	80128214	126526451	182859265	135525472	4025839579	3292239685	3577016767	3888648917	4037093707	4521845487	4273355015	5079009906
ADP	4063438688	4490458710	3554353544	4571710669	4275366446	3822977105	3333929188	3190020937	3237275601	2572226623	2636650174	2711604087	3175975432	3446659929	3318696821	3797237082
AMP	4126056968	4536124086	3667779048	4541566603	4163800377	3654802828	3245063605	296115205	3022757822	3019395455	2940922713	2999762706	2823053063	2884810581	2885486626	2543812554
ATP	63547267973	63724959198	65504286201	58995852037	65311628614	66968652034	69939579849	66161080272	1035164147	7895473992	798387881	8023780746	9416174972	1041805351	1083269526	122973388
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	PubChem ID	KEGG ID
Cytidine	6175	C00475
Uridine	6029	C00299
UMP	6030	C00105
UDP	6031	C00015
UTP	6133	C00075
CMP	6131	C00055
CDP	6132	C00112
CTP	6175	C00063
UDP-hexose	8629	C00029
AMP	6083	C00020
ADP	6022	C00008
ATP	5957	C00002
METABOLITES_END
#END